Abstract
Natural killer (NK)-cell lymphomas are aggressive and relapses occur early. Late relapses are exceptional. Ten relapses 17.5 (11-29) years after first complete remission (CR1) were analyzed. Initial diseases were stage-I (nasal, n = 8; tonsil, n = 1; ileum, n = 1), treated with radiotherapy (n = 6), combined radiotherapy/chemotherapy (n = 3), and chemotherapy (n = 1). Relapse occurred at the same (nasal, n = 6; tonsil, n = 1), adjacent (initial: nasal, relapse: palate; n = 1) or distant (n = 2) sites. Five patients died soon afterwards. Four patients remitted with chemotherapy, two remaining in CR2 (3, 14 years). This series documented the rare late relapses in NK-cell lymphomas, which may still respond to salvage therapy. © 2010 Wiley-Liss, Inc.
Cite
CITATION STYLE
Au, W. Y., Kim, S. J., Yiu, H. H. Y., Ngan, R. K. C., Loong, F., Kim, W. S., & Kwong, Y. L. (2010). Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission. American Journal of Hematology, 85(5), 362–363. https://doi.org/10.1002/ajh.21663
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.